glp-1 drugs oral New Outperforms Semaglutide With FDA approval of Wegovy
Description
No extra nausea
Role repositioning: the appropriate clinical role of GLP-1RAs is not to replace ovulation induction or ART, but to serve as a periconception metabolic optimization tool
[DOI] [PMC free article] [PubMed] [Google Scholar] 115.Filippatos TD, Panagiotopoulou TV, Elisaf MS
When used in combination with a sulfonylurea, metformin, or both, exenatide produces a decrease in A1C of less than 1 percentage point
Rare cases of drug-induced liver injury have been reported, but routine hepatotoxicity is not characteristic of semaglutide
